HEADER SIGNALING PROTEIN 10-AUG-20 7JQ8 TITLE SOLUTION NMR STRUCTURE OF HUMAN BRD3 ET DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NET DOMAIN, RESIDUES 554-640; COMPND 5 SYNONYM: RING3-LIKE PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: INTEGRASE PEPTIDE; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: C-TERMINAL TAIL, RESIDUES 1716-1738; COMPND 11 SYNONYM: IN, P46; COMPND 12 EC: 2.7.7.-,3.1.-.-; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD3, KIAA0043, RING3L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15_NESG; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: MOLONEY MURINE LEUKEMIA VIRUS (ISOLATE SOURCE 13 SHINNICK); SOURCE 14 ORGANISM_COMMON: MOMLV; SOURCE 15 ORGANISM_TAXID: 928306; SOURCE 16 STRAIN: ISOLATE SHINNICK; SOURCE 17 GENE: GAG-POL; SOURCE 18 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 20 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PET15_NESG KEYWDS BET PROTEINS, BRD3, EXTRA-TERMINAL DOMAIN, MLV-IN TP, SIGNALING KEYWDS 2 PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR S.AIYER,G.V.T.SWAPNA,J.M.ROTH,G.T.MONTELIONE REVDAT 4 15-MAY-24 7JQ8 1 REMARK REVDAT 3 14-JUN-23 7JQ8 1 REMARK REVDAT 2 18-AUG-21 7JQ8 1 JRNL REVDAT 1 23-JUN-21 7JQ8 0 JRNL AUTH S.AIYER,G.V.T.SWAPNA,L.C.MA,G.LIU,J.HAO,G.CHALMERS, JRNL AUTH 2 B.C.JACOBS,G.T.MONTELIONE,M.J.ROTH JRNL TITL A COMMON BINDING MOTIF IN THE ET DOMAIN OF BRD3 FORMS JRNL TITL 2 POLYMORPHIC STRUCTURAL INTERFACES WITH HOST AND VIRAL JRNL TITL 3 PROTEINS. JRNL REF STRUCTURE V. 29 886 2021 JRNL REFN ISSN 0969-2126 JRNL PMID 33592170 JRNL DOI 10.1016/J.STR.2021.01.010 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JQ8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251089. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298; 298; 298; 298 REMARK 210 PH : 7.0; 7.0; 7.0; 7.0 REMARK 210 IONIC STRENGTH : 100MM NACL; 100MM NACL; 100MM REMARK 210 NACL; 100MM NACL REMARK 210 PRESSURE : 1 ATM; 1 ATM; 1 ATM; 1 ATM REMARK 210 SAMPLE CONTENTS : 0.5 MM [U-100% 13C; U-100% 15N] REMARK 210 MLV IN TP, 100 MM SODIUM REMARK 210 CHLORIDE, 20 MM SODIUM PHOSPHATE, REMARK 210 2 MM 2-MERCAPTOETHANOL, 90% H2O/ REMARK 210 10% D2O; 0.5 MM [U-100% 13C; U- REMARK 210 100% 15N] BRD3 ET, 100 MM SODIUM REMARK 210 CHLORIDE, 20 MM SODIUM PHOSPHATE, REMARK 210 2 MM 2-MERCAPTOETHANOL, 90% H2O/ REMARK 210 10% D2O; 0.5 MM BRD3 ET, 100 MM REMARK 210 SODIUM CHLORIDE, 20 MM SODIUM REMARK 210 PHOSPHATE, 2 MM 2- REMARK 210 MERCAPTOETHANOL, 90% H2O/10% D2O; REMARK 210 0.5 MM BRD3 ET, 100 MM SODIUM REMARK 210 CHLORIDE, 20 MM SODIUM PHOSPHATE, REMARK 210 2 MM 2-MERCAPTOETHANOL, 90% H2O/ REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1D_1H; 2D HNOE; 2D NH-HSQC; 2D REMARK 210 CH-HSQC; 2D TROSY; 3D CBCA(CO)NH; REMARK 210 3D HBHA(CO)NH; 3D HNCA; 3D REMARK 210 HNCACB; 3D HCCH-TOCSY; 3D CN- REMARK 210 SIMNOESY; 2D_NH_HSQC; 2D_CHHSQC; REMARK 210 2D_CT_CHHSQC; 3D HNCO; 3D 12C- REMARK 210 14N_FILTERED NOESY; 2D-HOMONOESY- REMARK 210 13C15NFILTER; 3D AROMATIC -NOESY; REMARK 210 3D CN_SIMNOESY; 2D NHHSQC; 2D REMARK 210 NH-TROSY; 2D CHHSQC; 3D 12C_14N_ REMARK 210 NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, AUTOASSIGN, SPARKY, ASDP REMARK 210 2.3, NMRPIPE, TOPSPIN REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 27 99.09 -60.18 REMARK 500 1 GLN B 211 -76.23 44.84 REMARK 500 2 HIS A 3 42.49 -173.62 REMARK 500 2 HIS A 8 15.59 -141.49 REMARK 500 2 ASP A 18 82.53 -150.11 REMARK 500 2 PRO A 27 91.37 -67.05 REMARK 500 2 GLN B 211 -87.46 67.30 REMARK 500 2 LEU B 214 -64.72 -108.19 REMARK 500 3 HIS A 2 73.83 62.56 REMARK 500 3 PRO A 27 99.73 -59.58 REMARK 500 3 LYS A 95 -149.59 -132.43 REMARK 500 4 ALA A 15 91.52 -68.40 REMARK 500 4 PRO A 27 91.59 -63.50 REMARK 500 4 GLN B 211 -67.08 51.23 REMARK 500 5 HIS A 2 43.71 -164.93 REMARK 500 5 SER A 14 103.83 -163.33 REMARK 500 5 LEU B 203 92.94 -69.45 REMARK 500 6 LEU A 26 158.24 -49.09 REMARK 500 6 PRO A 27 106.71 -50.47 REMARK 500 6 GLN B 211 -65.69 69.36 REMARK 500 6 PRO B 213 -16.51 -44.26 REMARK 500 7 PRO A 27 106.11 -58.69 REMARK 500 8 HIS A 8 98.56 -165.69 REMARK 500 8 GLU A 20 -69.29 -155.09 REMARK 500 8 PRO A 27 106.30 -55.29 REMARK 500 8 SER B 210 -158.87 -84.52 REMARK 500 8 ARG B 220 87.52 -67.10 REMARK 500 9 HIS A 2 46.14 -90.61 REMARK 500 9 PRO B 213 38.44 -75.97 REMARK 500 9 LEU B 214 -56.22 -156.12 REMARK 500 10 PRO A 27 99.48 -66.89 REMARK 500 10 PRO A 44 -176.54 -69.06 REMARK 500 10 LYS A 95 96.15 -58.55 REMARK 500 11 MET A 9 105.52 -171.79 REMARK 500 11 GLU A 21 133.33 -170.68 REMARK 500 11 GLN A 94 64.47 65.10 REMARK 500 11 SER B 210 -157.85 -92.70 REMARK 500 12 HIS A 8 75.87 -160.88 REMARK 500 12 SER A 14 116.77 -161.51 REMARK 500 12 SER B 210 -169.85 -78.33 REMARK 500 12 GLN B 211 1.15 -66.34 REMARK 500 13 HIS A 5 103.15 -167.69 REMARK 500 13 MET A 9 110.79 -163.43 REMARK 500 13 GLN A 12 117.91 -165.65 REMARK 500 13 GLU A 20 142.31 69.31 REMARK 500 14 HIS A 2 86.37 -154.64 REMARK 500 14 PRO A 27 102.05 -59.09 REMARK 500 14 THR B 204 87.25 -69.92 REMARK 500 15 HIS A 2 134.17 -173.45 REMARK 500 15 MET A 9 107.95 -160.72 REMARK 500 REMARK 500 THIS ENTRY HAS 69 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7JMY RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF FREE BRD3 ET REMARK 900 RELATED ID: 30786 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF HUMAN BRD3 ET DOMAIN WITH MLV IN C- REMARK 900 TERMINAL TAIL PEPTIDE (TP) COMPLEX DBREF 7JQ8 A 10 96 UNP Q15059 BRD3_HUMAN 554 640 DBREF 7JQ8 B 201 223 UNP P03355 POL_MLVMS 1716 1738 SEQADV 7JQ8 HIS A 1 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 HIS A 2 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 HIS A 3 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 HIS A 4 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 HIS A 5 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 HIS A 6 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 SER A 7 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 HIS A 8 UNP Q15059 EXPRESSION TAG SEQADV 7JQ8 MET A 9 UNP Q15059 EXPRESSION TAG SEQRES 1 A 96 HIS HIS HIS HIS HIS HIS SER HIS MET GLY LYS GLN ALA SEQRES 2 A 96 SER ALA SER TYR ASP SER GLU GLU GLU GLU GLU GLY LEU SEQRES 3 A 96 PRO MET SER TYR ASP GLU LYS ARG GLN LEU SER LEU ASP SEQRES 4 A 96 ILE ASN ARG LEU PRO GLY GLU LYS LEU GLY ARG VAL VAL SEQRES 5 A 96 HIS ILE ILE GLN SER ARG GLU PRO SER LEU ARG ASP SER SEQRES 6 A 96 ASN PRO ASP GLU ILE GLU ILE ASP PHE GLU THR LEU LYS SEQRES 7 A 96 PRO THR THR LEU ARG GLU LEU GLU ARG TYR VAL LYS SER SEQRES 8 A 96 CYS LEU GLN LYS LYS SEQRES 1 B 23 SER ARG LEU THR TRP ARG VAL GLN ARG SER GLN ASN PRO SEQRES 2 B 23 LEU LYS ILE ARG LEU THR ARG GLU ALA PRO HELIX 1 AA1 SER A 29 ARG A 42 1 14 HELIX 2 AA2 PRO A 44 GLU A 59 1 16 HELIX 3 AA3 GLU A 59 ASN A 66 1 8 HELIX 4 AA4 LYS A 78 GLN A 94 1 17 SHEET 1 AA1 3 ILE A 70 ASP A 73 0 SHEET 2 AA1 3 LYS B 215 THR B 219 -1 O ILE B 216 N ILE A 72 SHEET 3 AA1 3 ARG B 206 ARG B 209 -1 N GLN B 208 O ARG B 217 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1